abstract |
The subject invention provides vaccines, vaccine components, and uses thereof suitable for providing immunity involving B-cell activating molecules derived from veterinary bacterial pathogens lipopolysaccharide (LPS), said molecules comprising one or more epitopes of the inner-core oligosaccharide portion of the lipopolysaccharide having the structure: A Figure 1 Where R and R' are variable outer care structures. |